Ginsenoside Re
CAS 52286-59-6
Ginsenoside Re (CAS 52286-59-6) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Ginsenoside Re used for in pharmaceutical contexts?
Ginsenoside Re (CAS 52286-59-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Ginsenoside Re?
No adverse-event association or SIDER side-effect rows are rendered for Ginsenoside Re in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Ginsenoside Re also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Ginsenoside Re.
What clinical phase is Ginsenoside Re in?
No phase 1-4 clinical development badge is rendered for Ginsenoside Re because the matched compound identifier rows do not contain a max-phase value.